Beteiligung seit 2020
PhagoMed develops phage-based drugs that work where antibiotics fail and protect the beneficial bacteria. Its focus is on synthetic lysins as the technology for all future development programs.
PhagoMed develops phage-based drugs that work where antibiotics fail and protect the beneficial bacteria. Its focus is on synthetic lysins as the technology for all future development programs.
